Organization: Queen’s University

The Short Report – May 8, 2019: Cannabis R&D, fuel cell demo, accelerator funding

With the goal becoming a mainstream healthcare company, Smiths Falls, ON-based Canopy Growth Corp. has spun off a new division – Spectrum Therapeutics – to oversee the company’s commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and recently acquired Germany-based C3Cannabinoid Compound Company, which develops cannabinoid-based medical therapies. – Canopy Growth…

New research network at Queen’s University addresses growing prevalence of Lyme disease in Canada

The Canadian Institutes of Health Research (CIHR) and the Government of Canada are investing $4 million in a new research network focused on the prevention, control, diagnosis, and treatment of Lyme disease. Operated by Queen’s University, the Pan-Canadian Research Network on Lyme Disease aims to influence health outcomes, practice, programs and policy related to Lyme…